-
Product Insights
C-X-C Chemokine Receptor Type 4 – Drugs In Development, 2023
Global Markets Direct’s C-X-C Chemokine Receptor Type 4 provides in depth analysis on C-X-C Chemokine Receptor Type 4 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in C-X-C...
-
Product Insights
C-X-C Chemokine Receptor Type 2 – Drugs In Development, 2023
Global Markets Direct’s C-X-C Chemokine Receptor Type 2 provides in depth analysis on C-X-C Chemokine Receptor Type 2 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in C-X-C...
-
Product Insights
C-X-C Chemokine Receptor Type 3 – Drugs In Development, 2023
Global Markets Direct’s C-X-C Chemokine Receptor Type 3 provides in depth analysis on C-X-C Chemokine Receptor Type 3 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in C-X-C...
-
Product Insights
C-X-C Chemokine Receptor Type 1 – Drugs In Development, 2023
Global Markets Direct’s C-X-C Chemokine Receptor Type 1 provides in depth analysis on C-X-C Chemokine Receptor Type 1 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in C-X-C...
-
Product Insights
C-X-3-C Motif Chemokine Receptor – Drugs In Development, 2023
Global Markets Direct’s C-X-3-C Motif Chemokine Receptor provides in depth analysis on C-X-3-C Motif Chemokine Receptor targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in C-X-3-C Motif Chemokine...
-
Product Insights
Hepatitis C – Drugs In Development, 2023
Global Markets Direct’s, ‘Hepatitis C - Drugs In Development, 2023’, provides an overview of the Hepatitis C pipeline landscape. The report provides comprehensive information on the therapeutics under development for Hepatitis C, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Apolipoprotein C – Drugs In Development, 2023
Global Markets Direct’s Apolipoprotein C provides in depth analysis on Apolipoprotein C targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Apolipoprotein C targeted therapeutics development and features...
-
Product Insights
Apolipoprotein C III – Drugs In Development, 2023
Global Markets Direct’s Apolipoprotein C III provides in depth analysis on Apolipoprotein C III targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Apolipoprotein C III targeted therapeutics...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Coagulation Factor II (human) + Coagulation Factor VII (human) + Coagulation Factor IX (human) + Coagulation Factor X (human) + Protein C (human)) in Blood Coagulation
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Coagulation Factor II (human) + Coagulation Factor VII (human) + Coagulation Factor IX (human) + Coagulation Factor X (human) + Protein C (human)) in Blood Coagulation report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine...
-
Product Insights
Protein Kinase C Theta Type – Drugs In Development, 2023
Global Markets Direct’s Protein Kinase C Theta Type provides in depth analysis on Protein Kinase C Theta Type targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Protein...